🔎 Trials Near Me

Hjem › Blærekreft › New Jersey › Edison

Kliniske studier for Blærekreft i Edison, NJ

21 studier for Blærekreft søker deltakere på steder i og rundt Edison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

RekruttererFase 3
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

RekruttererFase 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06770582

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

RekruttererFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RekruttererFase 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

RekruttererFase 1
  • MSK Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07206225

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

RekruttererFase 1
  • START Astera, LLC, East Brunswick · 6 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

RekruttererFase 3
  • Astera Cancer Care, East Brunswick · 6 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07218380

A Study of Surgical Techniques During Cystectomy

RekruttererFase 3
  • Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge · 15 mi unna
Alder 21 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06703476

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

RekruttererObservasjonsstudie
  • Astera Cancer Care, East Brunswick · 6 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

RekruttererFase 1/2
  • Rutgers Cancer Institute of New Jersey ( Site 0007), New Brunswick · 3 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07222488

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

RekruttererObservasjonsstudie
  • Rutgers Cancer Institute, New Brunswick · 3 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07144319

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Rekrutterer
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05837767

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

RekruttererFase 3
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07097142

Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)

RekruttererFase 2
  • Rutgers Cancer Institute, New Brunswick · 3 mi unna
Alder 18 til 90 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT07762586

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

RekruttererFase 1/2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
  • New Jersey Urology, LLC, Voorhees Township · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722

A Study of a Side Effects and Resource Navigation Program for People With Cancer

Rekrutterer
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT07646847

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

RekruttererFase 2
  • MSK Basking Ridge, Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT04879329

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Rekrutterer
  • Summit Health, Voorhees Township · 5 mi unna
Alder 18 til 88 · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06394869

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

RekruttererFase 2
  • Rutgers Cancer Institute, New Brunswick · 3 mi unna
Alder 18 til 99 · Alle kjønn · Oppdatert 6. mai 2026 · NCT06822010

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

RekruttererFase 1
  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. apr. 2026 · NCT05562791

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, New Brunswick · 3 mi unna
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Blærekreft-studier i andre byer

Andre studier i Edison

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.